Igreja da Misericórdia de Évora

(+351) 266 748 830
2ª a 6ª - 08:30 - 13:00 // 14:00 -17:30 | Sábado - 09:00 - 13:00 // 14:00 - 18:00 | Domingos e Feriados - Fechado

Top Marijuana Stocks in the NASDAQ

Top Marijuana Stocks in the NASDAQ

Top Marijuana Stocks in the NASDAQ

Even though greater part of U.S.-based cannabis organizations and lots of foreign American Depository Receipts (ADRs) trade throughout the counter (OTC), several cannabis organizations are exchanged in the NASDAQ. Some investors prefer stocks which are noted on the NASDAQ with other exchanges because of their increased liquidity and tighter spreads set alongside the over-the-counter areas. For instance, once the cannabis industry is continuing to grow in current months and years, uplisting from an OTC market to an established U.S. trade is becoming an advertising achievement for a lot of marijuana that is rising. (For associated reading, see “Understanding healthcare Cannabis vs. Recreational Cannabis shares”)

An increasing wide range of cannabis organizations are increasingly being noted on reputable U.S. exchanges in the place of being traded in the OTC market showing the quick development of the cannabis industry.

NASDAQ-listed Marijuana shares

The NASDAQ ended up being the initial electronic trade and is certainly synonymous with technology and biotechnology. The cannabis companies in the NASDAQ mirror this, as well as the most of them run when you look at the biotech area of this industry. Here you will find the NASDAQ-listed cannabis shares, in alphabetical order, at the time of October 26, 2019, with a failure of these total returns.

Arena Pharmaceuticals, Inc. (NASDAQ:ARNA)

Arena Pharmaceuticals is really a biotech business active in the production of medical cannabis drugs. Research and development around Arena’s APD371 may be the focus that is primary of firm’s cannabis biotech initiatives.

Atlantic Alliance Partnership Corp. (NASDAQ:AAPC)

Atlantic Alliance Partnership Corp. is really a check that is blank that is in a merger contract with Kalyx developing Inc. Kalyx is a respected owning a home rely upon the regulated cannabis industry in the usa.

Key Takeaways

  • The cannabis industry, specially the area of cannabis and biotech, is attracting significant investor attention.
  • Cannabis is being utilized in brand new medications to treat discomfort and chronic that is many inflammatory, and fibrotic conditions.
  • Organizations will also be developing cannabinoid services and products for autism range problems, schizophrenia, glioma, Tourette problem, epileptic problems, Prader-Willi Syndrome (a genetic condition), and addiction that is amphetamine.

Cara Therapeutics Inc. (NASDAQ:CARA)

Cara Therapeutics is a clinical-stage biotechnology company focused on developing and commercializing new chemical entities when it comes to indications of pain and pruritus (itching). Although all the company’s clinical-stage services and products target opioid receptors, Cara is conducting preclinical research on cannabinoids for the treating neuropathic discomfort.

Corbus Pharmaceuticals Holdings Inc. (NASDAQ:CRBP)

Corbus Pharmaceuticals Holdings Inc. is really a cannabis biotech company. The group’s research, development, and manufacturing are based around cannabis medications that look for to deal with chronic, inflammatory, fibrotic, as well as other diseases.

Cronos Group Inc. (NASDAQ:CRON)

Cronos Group Inc. is really A canadian cannabis business. The team has and seeks cannabis-related subsidiaries and producers that are licensed. In December of 2018, Marlboro manufacturer Altria announced plans to spend $1.8 billion in Cronos. The investment has provided Cronos not just with additional cash to fund its continued expansion but additionally with a well-established partner skilled when you look at the advertising of customer brands.

Greenlane Holdings Inc. (NASDAQ:GNLN)

Greenlane Holdings Inc. is a Boca Raton, Florida-based cannabis company. It distributes many different cannabis usage add-ons and vaporization gear and items to customers that are retail the U.S. and Canada. Also, it runs e-commerce web sites for extra sales.

GW Pharmaceuticals Plc. (NASDAQ:GWPH)

GW Pharmaceuticals is having a portfolio of cannabinoid medicines. These medications consist of Sativex for the treating spasticity linked to sclerosis that is multiple cancer tumors discomfort and Epidiolex to treat youth epilepsy. Sativex is commercialized much more than the usual dozen countries away from united states of america and contains received approval that is regulatory various other countries. Epidiolex received Food And Drug Administration approval being a therapy plan for Dravet Syndrome and Lennox-Gastaut Syndrome, two types of serious, very very early onset epilepsy without good current treatment plans. Other indications reveal that GW Pharmaceuticals is developing products that are cannabinoid autism range disorders, schizophrenia, and glioma.

Intec Pharma Ltd. (NASDAQ:NTEC)

Intec Pharma is just a clinical-stage biopharmaceutical business that is developing drugs centered on its proprietary Accordion Pill technology. Intec’s product pipeline includes cannabinoid-based medications for lower pain that is back fibromyalgia.

Marrone Bio Innovations, Inc. (NASDAQ:MBII)

Marrone Bio Innovations, Inc. develops and distributes environmentally accountable bio-based management that is pest plant health items. In 2017, Marrone Bio Innovations announced that three MBII active ingredients are now appropriate to be used on cannabis crops within the Ca cultivation market.

Modern Beverages Corp. (NASDAQ:NBEV)

Modern age Beverages Corp. is a maker of beverages based on yerba mate, green tea leaf, kombucha, and comparable products. In present months, modern age has expanded its beverage offerings to incorporate CBD infusions also, bringing it in to the orbit of cannabis shares.

OrganiGram Holdings Inc. (NASDAQ:OGI)

Canadian cannabis producer OrganiGram Holdings Inc. debuted in the NASDAQ in might of 2019, which makes it perhaps one of the most current cannabis businesses to record in the exchange that is popular. The organization happens to be rapidly expanding its manufacturing capability that will have the ability to create up to 113,000 kilograms of item per by the end of 2019 year.

Psychemedics Corporation (NASDAQ:PMD)

Psychemedics Corporation operates when you look at the enforcement sector. The business’s business operations support medication evaluation through hair samples.

Sundial Growers Inc. (NASDAQ:SNDL)

Alberta, Canada-based Sundial Growers Inc. is another brand new entry on the NASDAQ change. The cannabis producer made headlines in October of 2019 (and saw a quick price boost) whenever it announced the production of a new Palmetto make of leisure cannabis, first for sale in Saskatchewan and Manitoba.

Therapix Biosciences Ltd. (NASDAQ:TRPX)

Therapix Biosciences Ltd. is just a specialty clinical-stage company that is pharmaceutical in the growth of cannabinoid-based medications. Therapix’s current pipeline includes items targeted for the treatment of Tourette problem and mild impairment that is cognitive.

Tilray Inc. (NASDAQ:TLRY)

Tilray Inc. ended up being the very first company that is marijuana-related have a preliminary general public providing (IPO) in the usa. The Nanaimo, Vancouver company that is island-based on medical cannabis services and products.

Village Farms International (NASDAQ:VFF)

Village Farms Overseas is one of cannabis that are recent to begin investing from the NASDAQ. The business’s stocks became readily available for trade on February 21, 2019. The business possesses history that is decades-long greenhouse produce manufacturing where to buy cbd oil and it has just recently shifted a number of its focus toward cannabis manufacturing.

Zynerba Pharmaceuticals Inc. (NASDAQ:ZYNE)

Zynerba Pharmaceuticals is targeted from the growth of artificial cannabinoid remedies for transdermal (through the skin) delivery. Their pipeline presently includes two medications being developed for indications epilepsy that is including osteoarthritis, fibromyalgia, peripheral neuropathic discomfort, and delicate X syndrome.

Deixe um comentário

O seu endereço de email não será publicado. Campos obrigatórios marcados com *

Subscribe to Our Newsletter
Do not miss the interesting news and be always in a trend